Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity
Small · 2024-03 · 20 (10)
DOI: 10.1002/smll.202306892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 22.10.2023. Verfasst von Alexander Lamoot und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Ghent University, Ghent, 9000, Belgium. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Poly I-C, Liposomes, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: European Research Council, NIDDK NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Poly(I:C) is a synthetic analogue of dsRNA capable of activating both TLR3 and RLRs, such as MDA‐5 and RIG‐I, as pathogen recognition receptors. While poly(I:C) is known to provoke a robust type I IFN, type III IFN, and Th1 cytokine response, its therapeutic use as a vaccine adjuvant is limited due to its vulnerability to nucleases and poor uptake by immune cells. is encapsulated poly(I:C) into lipid nanoparticles (LNPs) containing an ionizable cationic lipid that can electrostatically interact with poly(I:C). LNP‐formulated poly(I:C) triggered both lysosomal TLR3 and cytoplasmic RLRs, in vitro and in vivo, whereas poly(I:C) in an unformulated soluble form only triggered endosomal‐localized TLR3. Administration of LNP‐formulated poly(I:C) in mouse models led to efficient translocation to lymphoid tissue and concurrent innate immune activation following intramuscular (IM) administration, resulting in a significant increase in innate immune activation compared to unformulated soluble poly(I:C). When used as an adjuvant for recombinant full‐length SARS‐CoV‐2 spike protein, LNP‐formulated poly(I:C) elicited potent anti‐spike antibody titers, surpassing those of unformulated soluble poly(I:C) by orders of magnitude and offered complete protection against a SARS‐CoV‐2 viral challenge in vivo, and serum from these mice are capable of significantly reducing viral infection in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Ghent University, Ghent, 9000, Belgium.
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
- Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
- Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
- Biosafety Research Institute, College of Veterinary Medicine, Jeonbuk National University, Iksan, 54596, South Korea.
- Laboratory of Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent University, Ghent, 9000, Belgium.
ORCID-Profile: Bruno G De Geest
Förderung
- European Research Council
- NIDDK NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Korea Health Industry Development Institute
Zitieren
APA
Lamoot, A., Jangra, S., Laghlali, G., Warang, P., Singh, G., Chang, L. A., Park, S. C., Singh, G., De Swarte, K., Zhong, Z., Louage, B., De Lombaerde, E., Ye, T., Chen, Y., Cuadrado-Castano, S., Lienenklaus, S., Sanders, N. N., Lambrecht, B. N., García-Sastre, A., …, & De Geest, B. G. (2024). Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity. Small, 20(10). https://doi.org/10.1002/smll.202306892
Vancouver
Lamoot A, Jangra S, Laghlali G, Warang P, Singh G, Chang LA, et al. Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity. Small. 2024;20(10). doi:10.1002/smll.202306892
BibTeX
@article{Lamoot2024,
author = {Lamoot, Alexander and Jangra, Sonia and Laghlali, Gabriel and Warang, Prajakta and Singh, Gagandeep and Chang, Lauren A and Park, Seok-Chan and Singh, Gagandeep and De Swarte, Kim and Zhong, Zifu and Louage, Benoit and De Lombaerde, Emily and Ye, Tingting and Chen, Yong and Cuadrado-Castano, Sara and Lienenklaus, Stefan and Sanders, Niek N and Lambrecht, Bart N and García-Sastre, Adolfo and Schotsaert, Michael and De Geest, Bruno G},
title = {Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity},
journal = {Small},
year = {2024},
volume = {20},
number = {10},
doi = {10.1002/smll.202306892}
}
EUVIMED